Pulse Biosciences Inc Company Profile
NASDAQ: PLSEHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 53.81 0.00%
Pulse Biosciences at a glance
Pulse Biosciences Inc (NASDAQ: PLSE) is a Medical/Dental Instruments company in the Health Care sector headquartered in Miami, FL. Pulse Biosciences is led by Mr. Paul Arthur LaViolette M.B.A. and employs about 116 people. The company's shares have traded publicly since 2016.
At a market capitalization of $3.50 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001625101, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Pulse Biosciences do?
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Business description based on the company's public filings.
Company information
- Legal name
- Pulse Biosciences Inc
- Ticker
- NASDAQ: PLSE
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Paul Arthur LaViolette M.B.A.
- Employees
- 116
- Headquarters
- 601 Brickell Key Drive, Miami, FL, United States
- Phone
- 510 906 4600
- Website
- pulsebiosciences.com
- IPO year
- 2016
- Market cap
- $3.50B
- SEC CIK
- 0001625101
Companies similar to Pulse Biosciences
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IRTCiRhythm Holdings Inc. | 106.70 | +4.00% | $3.52B | vs PLSE |
| NVSTEnvista Holdings Corporation | 23.00 | +1.23% | $3.69B | vs PLSE |
| ICUIICU Medical Inc. | 160.32 | +2.00% | $4.01B | vs PLSE |
| ATRCAtriCure Inc. | 55.81 | +5.62% | $2.84B | vs PLSE |
| HTFLHeartflow Inc. | 49.74 | +4.43% | $4.33B | vs PLSE |
| UFPTUFP Technologies Inc. | 288.97 | +0.84% | $2.24B | vs PLSE |
| INSPInspire Medical Systems Inc. | 68.89 | +3.30% | $1.99B | vs PLSE |
| LMATLeMaitre Vascular Inc. | 80.69 | +1.32% | $1.85B | vs PLSE |